Clicky

Elite Pharma Inc(ELTP)

Description: Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and the NDA for SequestOx™, for which it received the CRL from the FDA. Elite’s lead pipeline products include abuse-deterrent opioids which utilize the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.


Keywords: Pharmaceutical Drugs Euphoriants Psychoactive Drugs Contract Manufacturing Chronic Pain Opioids Morphinans Drug Products Heroin Morphine Epic Generic Products Bausch Health Gmp

Home Page: www.elitepharma.com

165 Ludlow Avenue
Northvale, NJ 07647
United States
Phone: 201 750 2646


Officers

Name Title
Mr. Nasrat Hakim Chairman, CEO & Pres
Mr. Douglas Plassche Exec. VP of Operations
Mr. Robert Chen CFO, Sec. & Treasurer
Ms. Dianne Will VP of Investor Relations & Corp. Affairs
Dr. George Kenneth Smith J.D., M.B.A., Ph.D. VP of Legal
Dr. Sophy Abraham Head of Regulatory Affairs
Mr. Kirko Kirkov Chief Commercial Officer

Exchange: OTCQB

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 3
Price-to-Book MRQ: 1.1186
Price-to-Sales TTM: 0.9244
IPO Date: 1998-07-23
Fiscal Year End: March
Full Time Employees: 43
Back to stocks